# Revalia Bio, Inc. — Form D

Revalia Bio, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-06. The offering totals $17.0M, of which $12.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-11-06
- Form: D
- Accession: 0002043834-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.0M
- Amount sold: $12.3M
- Remaining: $4.7M
- Investors: 32
- Date of first sale: 2024-10-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-528748

## Issuer

- Name: Revalia Bio, Inc.
- CIK: 0002043834
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 55 CHURCH STREET, NEW HAVEN, CT, 06510
- Phone: (312) 520-8301

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Milad T Alucozai | Director | West Lafayette, IN |
| Gregory T Tietjen | Director | New Haven, CT |
| Brian T Wilcove | Director | San Francisco, CA |
| Gregory T Tietjen | Executive Officer | New Haven, CT |

## More

- [CIK 2043834 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2043834&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002043834-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.